Courses target Chinese drug makers

Industry group ISPE is partnering with the China Centre for Pharmaceutical International Exchange (CCPIE) to bring training courses tailored to the needs of the Chinese pharmaceutical industry. Industry leader Gordon Farquharson will be presenting courses on sterile drug manufacturing facilities and pharmaceutical water systems.

The Sterile Drug Manufacturing Facilities: Applying ISPE Baseline Guide, FDA, EU/PICS and WHO Principles to Design and Operation course will review ISPE's sterile manufacturing facilities baseline guide, the FDA's 2004 Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing--Current Good Manufacturing Practice, and the March 2009 implementation of Annex 1 of the EU GMP, according to an announcement. The course is intended to help participants understand the key requirements and GMPs for sterile product manufacturing facilities.

In the second course, Pharmaceutical Water Systems: Regulation, Purification, Distribution and Validation, participants will review the principles of design and operation of water systems used in pharmaceutical manufacturing, including the regulatory requirements, concepts, and principles for systems used to generate, store and distribute both compendial and non-compendial waters.

- read the course descriptions

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.